Iron Gate Global Advisors’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Other funds holding PDSB
Iron Gate Global Advisors's PDSB Position: Q3 2026 in Review
Iron Gate Global Advisors reduced its PDS Biotechnology (PDSB) stake by 17% in Q3 2026, selling an estimated $6.84K and leaving 58,373 shares worth $43.8K. The position accounts for ﹤0.01% of the portfolio, ranked #105.
Iron Gate Global Advisors first reported a position in PDSB in Q3 2019 and has held it in 20 quarters since. The position peaked at $990K in Q4 2022. 60 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.
- Iron Gate Global Advisors held 58,373 shares of PDS Biotechnology worth $43.8K as of Q3 2026.
- Iron Gate Global Advisors sold 12,033 PDS Biotechnology shares in Q3 2026, an estimated $6.84K.
- PDS Biotechnology made up ﹤0.01% of Iron Gate Global Advisors's portfolio in Q3 2026, its #105 holding.
- Iron Gate Global Advisors first reported a position in PDS Biotechnology in Q3 2019 and has held it in 20 quarters since.
- Iron Gate Global Advisors's PDS Biotechnology position peaked at $990K in Q4 2022.
- 60 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.
Based on Iron Gate Global Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.